Articles From: Genworth Announces Partnership with Maria Shriver and Unveils "Conversations That Matter: Maria Shriver and Rob Lowe" to Georgia Power names 2014 New Teacher Assistance Grant recipients


Learn how Genworth is encouraging families to have "the talk" around long term care planning this holiday with help from Maria Shriver and Rob Lowe RICHMOND, Va.
Sign-up for Genworth Announces Partnership with Maria Shriver and Unveils "Conversations That Matter: Maria Shriver and Rob Lowe" investment picks
RICHMOND, Va.
Sign-up for Genworth Financial Announces Third Quarter 2014 Earnings Results investment picks
2014/12/1
Provides Growth, Protection and Guaranteed Income RICHMOND, Va.
Sign-up for Genworth Introduces New Fixed Index Annuity With Lifetime Income Rider investment picks
70% of Americans Age 65 or Older Will Require Some Form of Long Term Care1 RICHMOND, Va.
Sign-up for Genworth Launches R70 Age Simulation Suit to Help Americans Think Long Term investment picks
RICHMOND, Va.
Sign-up for Genworth Responds To Recent Ratings Actions investment picks
2014/11/13
Americans' Negative Emotions Associated with Long Term Care Conversations Create Serious Barriers to Proper Planning RICHMOND, Va.
Sign-up for Genworth Study Reveals Americans Would Rather Go to the Dentist Than Talk about Their Long Term Care Planning and Aging Needs investment picks
2014/12/11
RALEIGH, N.C. , Dec.
Sign-up for Genworth U.S. Mortgage Insurance partnership with Axacore, first in MI field, caps a year of renewed tech focus investment picks
Genzyme , a Sanofi company, and Isis Pharmaceuticals Inc. (NASDAQ: ISIS), today announced that new two-year data from a phase 3 long-term extension study of KYNAMRO ® (mipomersen sodium) injection was presented at a scientific session at the annual American Heart Association meeting in Chicago, IL.
Sign-up for Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association investment picks
Genzyme , a Sanofi company, announced today enrollment of the first patient in a multicenter Phase II clinical trial to evaluate Genzyme’s investigational infusion therapy vatelizumab in patients with relapsing remitting multiple sclerosis (RRMS). The trial, called EMPIRE, is designed to assess the efficacy of vatelizumab vs.
Sign-up for Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis investment picks
MINNEAPOLIS, Dec.
Sign-up for Geoffrey Moore to Deliver Keynote Address at Annual SPS In:fluence 2015 Event investment picks
NORWALK, Conn., Nov.
Sign-up for Geographic Revenue Exposure Data Now Available in FactSet Portfolio Analytics investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0985548001&sourceType=1 http://media3.marketwire.com/logos/20111208-GEOBIG.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Geologix Completes $599,000 Convertible Note Offering investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978610001&sourceType=1 http://media3.marketwire.com/logos/20111208-GEOBIG.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Geologix Update and Private Placement Offer investment picks
http://media.marketwire.com/attachments/200903/510648_HorizontalOutlineLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157401&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for GeoMet Announces Voting Results From Annual Meeting of Stockholders investment picks
2014/11/25
Today marks the newest addition to the Sierra™ library of games with the release of Geometry Wars 3: Dimensions.
Sign-up for Geometry Wars 3: Dimensions Available Now investment picks
SANTIAGO, Chile , Dec.
Sign-up for Geopark Announces Share Repurchase Program investment picks
2014/11/19
SANTIAGO, Chile , Nov.
Sign-up for GeoPark Reports Results for the Third Quarter Ended September 30, 2014 investment picks
2014/11/20
Former Pimco chief Bill Gross, who recently set up shop at Janus Capital, just received $500 million to manage on behalf of hedge-fund legend George Soros.
Sign-up for George Soros invests $500 million with Bill Gross investment picks
Georgetown Bancorp, Inc. (NASDAQ: GTWN) (the “Company”), holding company for Georgetown Bank (the “Bank”), reported net income for the three months ended September 30, 2014 of $390,000, or $.22 per basic and diluted share, compared to net income of $168,000, or $.09 per basic and diluted share, for the three months ended September 30, 2013.
Sign-up for Georgetown Bancorp, Inc. Reports 107% Increase in Earnings per Share for the Nine Months Ended September 30, 2014 and Announces Quarterly Cash Dividend investment picks
2014/12/9
Free app for Apple and Android devices delivers most popular content directly to customers ATLANTA , Dec.
Sign-up for Georgia Power "on the go" with new mobile app investment picks
2014/11/26
Company matches every dollar of customer donations; more than $64 million contributed since 1985 ATLANTA , Nov.
Sign-up for Georgia Power launches annual Project SHARE holiday campaign investment picks
2014/11/17
Company rolls out multi-year, industry-leading initiative to encourage adoption of electric vehicles ATLANTA , Nov.
Sign-up for Georgia Power launches EV charger rebate program for businesses investment picks
Company a leader in cost-effective solar development; anticipates more than 900 MW in place by 2016 ATLANTA , Oct.
Sign-up for Georgia Power named 2014 Investor-Owned Utility of the Year by Solar Electric Power Association investment picks
2014/11/21
$327,000 in individual grants awarded to new teachers during program's 10-plus year history ATLANTA , Nov.
Sign-up for Georgia Power names 2014 New Teacher Assistance Grant recipients investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Genworth Announces Partnership with Maria Shriver and Unveils "Conversations That Matter: Maria Shriver and Rob Lowe" to Georgia Power names 2014 New Teacher Assistance Grant recipients
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent